US drugmaker Regeneron under fire for ‘excessive’ payouts to executives


Sumary of US drugmaker Regeneron under fire for ‘excessive’ payouts to executives:

  • Instead it will replace them with an upfront five-year grant of performance-restricted stock units worth $130m (£92m) for each of its top two executives – Leonard Schleifer, the Regeneron chief executive, and George Yancopoulos, the chief scientific officer..
  • Regeneron is supplying the US government with millions of doses of its Covid antibody cocktail REGEN-COV, after receiving emergency authorisation for the treatment in November…

Want to know more click here go to source.

From -
Generic selectors
Exact matches only
Search in title
Search in content

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.